Overview

Mirena Observational Program

Status:
Completed
Trial end date:
2015-11-01
Target enrollment:
Participant gender:
Summary
Mirena is used for long-term in Kazakhstan, and in our observational program we would like to study patients distribution per indications of Mirena, and also patient compliance within a year after Mirena insertion. For patients with all approved indications for Mirena use: contraception, treatment of menorrhagia and protection from endometrial hyperplasia during estrogen replacement therapy
Details
Lead Sponsor:
Bayer
Treatments:
Levonorgestrel